CNBX
Price:
$0.0004
Market Cap:
$37.01K
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids f...[Read more]
Industry
Biotechnology
IPO Date
2007-09-04
Stock Exchange
OTC
Ticker
CNBX
According to CNBX Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.01. This represents a change of -39.18% compared to the average of 0.01 of the last 4 quarters.
The mean historical Current Ratio of CNBX Pharmaceuticals Inc. over the last ten years is 2.14. The current 0.01 Current Ratio has changed -65.94% with respect to the historical average. Over the past ten years (40 quarters), CNBX's Current Ratio was at its highest in in the November 2018 quarter at 17.54. The Current Ratio was at its lowest in in the May 2025 quarter at 0.01.
Average
2.14
Median
0.67
Minimum
0.01
Maximum
9.81
Discovering the peaks and valleys of CNBX Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.09%
Maximum Annual Current Ratio = 9.81
Minimum Annual Increase = -93.51%
Minimum Annual Current Ratio = 0.01
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.01 | -41.33% |
| 2024 | 0.01 | -85.98% |
| 2023 | 0.09 | 9.85% |
| 2022 | 0.08 | -93.51% |
| 2021 | 1.25 | -38.88% |
| 2020 | 2.04 | -79.16% |
| 2019 | 9.81 | 226.57% |
| 2018 | 3.01 | -40.27% |
| 2017 | 5.03 | 11.09% |
| 2016 | 0.04 | -40.33% |
The current Current Ratio of CNBX Pharmaceuticals Inc. (CNBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.04
5-year avg
0.29
10-year avg
2.14
CNBX Pharmaceuticals Inc.’s Current Ratio is less than GeneLink, Inc. (0.42), greater than Endonovo Therapeutics, Inc. (0.00), less than Microart Inc. (0), less than RVL Pharmaceuticals plc (2.89), less than Acura Pharmaceuticals, Inc. (0.72), less than Tian'an Pharmaceutical Co., Ltd. (0.06), less than Itoco Inc. (0.85), less than Filament Health Corp. (0.44), less than Affymax, Inc. (0.71), less than Naturally Splendid Enterprises Ltd. (0.48),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.42 | $10.60K | |
| 0.00 | $31.88K | |
| 0 | $26.15K | |
| 2.89 | $3.14M | |
| 0.72 | $6.60K | |
| 0.06 | $51.78K | |
| 0.85 | $34.10K | |
| 0.44 | $26.18K | |
| 0.71 | $41.24K | |
| 0.48 | $881.66K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNBX Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CNBX Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CNBX Pharmaceuticals Inc.'s Current Ratio?
How is the Current Ratio calculated for CNBX Pharmaceuticals Inc. (CNBX)?
What is the highest Current Ratio for CNBX Pharmaceuticals Inc. (CNBX)?
What is the 3-year average Current Ratio for CNBX Pharmaceuticals Inc. (CNBX)?
What is the 5-year average Current Ratio for CNBX Pharmaceuticals Inc. (CNBX)?
How does the current Current Ratio for CNBX Pharmaceuticals Inc. (CNBX) compare to its historical average?